Piperacillin and Tazobactam
Active substance: PIPERACILLIN SODIUM, TAZOBACTAM SODIUM
INJECTION, POWDER, FOR SOLUTION · PIPERACILLIN SODIUM 36 g/180mL, TAZOBACTAM SODIUM 4.5 g/180mL
United StatesActive
Marketing holder: Fresenius Kabi USA, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- PIPERACILLIN SODIUM · 36 g/180mL
- TAZOBACTAM SODIUM · 4.5 g/180mL
Registration
- Registration number
- 63323-304
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 63323-304 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63323-304 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63323-304 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 63323-304 · Verified 2026-10-09 · open in source